Saga K - Search Results

1

Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effects.

Ishibashi A, Li Y, Hisatomi Y, Ohta N, Uegaki Y, Tanemura A, Ohashi R, Kitamura K, Saga K, Yoshimura Y, Inubushi S, Ishida K, Iwabuchi S, Hashimoto S, Kiyohara E, Yagita H, Kaneda Y, Nimura K. Ishibashi A, et al. Among authors: saga k. Mol Ther Oncol. 2024 Oct 10;32(4):200893. doi: 10.1016/j.omton.2024.200893. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39534532 Free PMC article.

2

DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression.

Umeki Y, Ogawa N, Uegaki Y, Saga K, Kaneda Y, Nimura K. Umeki Y, et al. Among authors: saga k. Cell Mol Life Sci. 2022 Dec 23;80(1):17. doi: 10.1007/s00018-022-04640-4. Cell Mol Life Sci. 2022. PMID: 36564568 Free PMC article.

3

Virosome presents multimodel cancer therapy without viral replication.

Saga K, Kaneda Y. Saga K, et al. Biomed Res Int. 2013;2013:764706. doi: 10.1155/2013/764706. Epub 2013 Dec 4. Biomed Res Int. 2013. PMID: 24369016 Free PMC article. Review.

4

Oncolytic Sendai virus-based virotherapy for cancer: recent advances.

Saga K, Kaneda Y. Saga K, et al. Oncolytic Virother. 2015 Oct 1;4:141-7. doi: 10.2147/OV.S66419. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512677 Free PMC article. Review.

5

SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.

Kawamura N, Nimura K, Saga K, Ishibashi A, Kitamura K, Nagano H, Yoshikawa Y, Ishida K, Nonomura N, Arisawa M, Luo J, Kaneda Y. Kawamura N, et al. Among authors: saga k. Cancer Res. 2019 Oct 15;79(20):5204-5217. doi: 10.1158/0008-5472.CAN-18-3965. Epub 2019 Aug 20. Cancer Res. 2019. PMID: 31431456

6

Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens.

Kitamura K, Nimura K, Ito R, Saga K, Inohara H, Kaneda Y. Kitamura K, et al. Among authors: saga k. Sci Rep. 2020 Dec 17;10(1):22138. doi: 10.1038/s41598-020-78345-8. Sci Rep. 2020. PMID: 33335126 Free PMC article.

7

A simple method using CRISPR-Cas9 to knock-out genes in murine cancerous cell lines.

Ishibashi A, Saga K, Hisatomi Y, Li Y, Kaneda Y, Nimura K. Ishibashi A, et al. Among authors: saga k. Sci Rep. 2020 Dec 18;10(1):22345. doi: 10.1038/s41598-020-79303-0. Sci Rep. 2020. PMID: 33339985 Free PMC article.

8

Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production.

Saga K, Tamai K, Yamazaki T, Kaneda Y. Saga K, et al. Clin Cancer Res. 2013 Feb 1;19(3):668-79. doi: 10.1158/1078-0432.CCR-12-1947. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251005

9

Author Correction: Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens.

Kitamura K, Nimura K, Ito R, Saga K, Inohara H, Kaneda Y. Kitamura K, et al. Among authors: saga k. Sci Rep. 2021 Jun 4;11(1):12250. doi: 10.1038/s41598-021-91694-2. Sci Rep. 2021. PMID: 34088968 Free PMC article. No abstract available.

10

Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene.

Jiang Y, Saga K, Miyamoto Y, Kaneda Y. Jiang Y, et al. Among authors: saga k. Oncotarget. 2016 Jun 14;7(24):36034-36048. doi: 10.18632/oncotarget.9105. Oncotarget. 2016. PMID: 27145280 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters